MedDataX Logo

Supported Employment for Refugees

NCT03629366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-09-16

No results posted yet for this study

Summary

Humanitarian crises related to the Syrian conflict have led to a large increase in refugees in Europe in the recent years. There is need for effective approaches to increase labor market participation among refugees, and to reduce the impact of unfavorable exclusion mechanisms among this group. The Supported Employment for Refugees (the SER-trial) is a randomized controlled trial investigating the effectiveness of Supported Employment (SE) for newly arrived refugees who are involved in the mandatory introduction program provided for all refugees in Norway. SE is an intervention that has proved effective in promoting competitive employment among patients with severe mental illness in over twenty international randomized controlled trials, and is currently being evaluated for various new patient groups in ongoing trials. The SER-trial is however the first trial to evaluate the effect of SE for the target group of refugees (who may or may not have mental illness).

Conditions

  • Refugees

Interventions

BEHAVIORAL

Supported Employment (SE)

Supported Employment

BEHAVIORAL

Treatment as usual (TAU)

Treatment as usual

Sponsors & Collaborators

  • Norwegian Labour and Welfare Administration

    collaborator OTHER

  • NORCE Norwegian Research Centre AS

    lead OTHER

Principal Investigators

  • Vigdis Sveinsdottir, PhD · NORCE Norwegian Research Centre

  • Tonje Fyhn · NORCE Norwegian Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2020-04-30
Completion
2020-05-30

Countries

  • Norway

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629366 on ClinicalTrials.gov